Reducing the complications of type II diabetes: A patient-centered approach

American Family Physician

Volumn 56, Issue 2, 1997, Pages 471-478

  Susman, Jeffrey L ^a   Helseth, Lynn D ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BIGUANIDE DERIVATIVE; GLIBENCLAMIDE; GLIPIZIDE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; METFORMIN; MIGLITOL; SULFONYLUREA DERIVATIVE; TROGLITAZONE;

BLOOD GLUCOSE MONITORING; DIABETES CONTROL; DIET THERAPY; DYSLIPIDEMIA; EXERCISE; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; HYPERTENSION; INSULIN TREATMENT; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATIENT CARE; PATIENT EDUCATION; QUALITY OF LIFE; REVIEW; RISK FACTOR; SMOKING;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; PATIENT CARE PLANNING; PATIENT COMPLIANCE; REFERRAL AND CONSULTATION;

EID: 0030739623     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Current estimates from the National Health Interview Survey, 1993. Vital Health Stat [10] 1994;190:1-221.
2. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987;36:523-34.
3. Flegal KM, Ezzati TM, Harris MI, Haynes SG, Juarez RZ, Knowler WC, et al. Prevalence of diabetes in Mexican Americans, Cubans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey, 1982-1984. Diabetes Care 1991;14:628-38.
4. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 1993;16:157-77.
5. Rubin RJ, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994;78:809A-F.
6. Department of Health and Human Services, Agency for Health Care Policy and Research. National medical expenditure survey, 1987: household survey: prescribed medicine data (public use tape 14.1). Ann Arbor, Mich.: Inter-university Consortium for Political and Social Research, 1992.
7. Department of Health and Human Services, Agency for Health Care Policy and Research. National medical expenditure survey, 1987: ambulatory medical visit data (public use tape 14.5). Ann Arbor, Mich.: Inter-university Consortium for Political and Social Research, 1993.
8. Levetan C, Ratner R. The economic bottom line on preventive diabetes care. Pract Diabetol 1995; Dec:10-8.
9. Laws A, Marcus EB, Grove JS, Curb JD. Lipids and lipoproteins as risk factors for coronary heart disease in men with abnormal glucose tolerance: the Honolulu Heart Program. J Intern Med 1993;234: 471-8.
10. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141-7.
11. Ochi JW, Melton LJ 3d, Palumbo PJ, Chu CP. A population-based study of diabetes mortality. Diabetes Care 1985;8:224-9.
12. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988;128:389-401.
13. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes. Am J Public Health 1991;81:1158-62.
14. Bender AP, Sprafka JM, Jagger HG, Muckala KH, Martin CP, Edwards TR. Incidence, prevalence, and mortality of diabetes mellitus in Wadena, Marshall, and Grand Rapids, Minnesota: the Three-City study. Diabetes Care 1986;9:343-50.
15. McDowell A, Engel A, Massey JT, Maurer K. Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980. Vital Health Stat [1] 1981;15:1-144.
16. Plan and operation of the Hispanic Health and Nutrition Examination Survey 1982-84. Vital Health Stat [1] 1985;19:15.
17. Nilsson SV, Nilsson JE, Frostberg N, Emilsson T. The Kristianstad survey. II. Studies in a representative adult diabetic population with special reference to comparison with an adequate control group. Acta Med Scand Suppl 1967;469:1-42.
18. Kittner SJ, White LR, Losonczy KG, Wolf PA, Hebel JR. Black-white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA 1990;264:1267-70.
19. Vision problems in the U.S. Data analysis, definitions, data sources, detailed data tables, analyses, interpretation. New York: National Society to Prevent Blindness, 1980.
20. Klein R, Klein BE, Moss SE. The epidemiology of ocular problems in diabetes mellitus. In: Feman SS, ed. Ocular problems in diabetes mellitus. Boston: Blackwell Scientific, 1992:1-53.
21. U.S. Renal Data System: USRDS 1994 annual data report. Bethesda, Md.: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1994.
22. Knowler WC, Kunzelman CL. Population comparisons of the frequency of nephropathy. In: Mogensen CE, ed. The kidney and hypertension in diabetes mellitus. Boston: Nijhoff, 1988:25-32.
23. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 1989;111:788-96.
24. Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993;16:1446-52.
25. Diabetes in America. 2d ed. Bethesda, Md.: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995; NIH publication no. 95-1468.
26. Adams PF, Benson V. Current estimates from the National Health interview survey, 1991. Vital Health Stat [10] 1992;(184):1-232.
27. Adams PF, Benson V. Current estimates from the National Health interview survey, 1989. Vital Health Stat [10] 1990;(176):1-121.
28. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
29. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 1996;45:1289-98.
30. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19 (Suppl):789-830.
31. 1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study. Diabetes 1985;34:793-8.
32. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study II: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124(1 Pt 2):136-45.
33. Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 1995;18:1113-23.
34. Bierman EL. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-56.
35. Medical management of non-insulin-dependent (type II) diabetes. 3d ed. Alexandria, Va.: American Diabetes 1994:26.
36. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1994;17:616-23.
37. Lorenz RA, Bubb J, Davis D, Jacobson A, Jannasch K, Kramer J, et al. Changing behavior. Practical lessons from the Diabetes Control and Complications Trial. Diabetes Care 1996;19:648-52.
38. Clark CM, Vinicor F. Introduction: risks and benefits of intensive management in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996;124(Suppl 1, Pt 2):81-5.
39. Connell CM. Psychosocial contexts of diabetes and older adulthood: reciprocal effects. Diabetes Educ 1991;17:364-71.
40. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-44.
41. Peterson KA. Diabetes care by primary care physicians in Minnesota and Wisconsin. J Fam Pract 1994;38(4):361-7.
42. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 1996;19:1153-64.
43. O'Connor PJ, Crabtree BF, Abourizk NN. Longitudinal study of a diabetes education and care intervention: predictors of improved glycemic control. J Am Board Fam Pract 1992;5:381-7.
44. Vinicor F, Cohen SJ, Mazzuca SA, Moorman N, Wheeler M, Kuebler T, et al. DIABEDS: a randomized trial of the effects of physician and/or patient education on diabetes patient outcomes. J Chronic Dis 1987;40:345-56.
45. Nicolucci A, Cavaliere D, Scorpiglione N, Carinci F, Capani F, Tognoni G, et al. A comprehensive assessment of the avoidability of long-term complications of diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration. Diabetes Care 1996;19:927-33.
46. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med 1992;15:447-68.
47. Gilden JL, Hendryx MS, Clar S, Casia C, Singh SP. Diabetes support groups improve health care of older diabetic patients. J Am Geriatr Soc 1992; 40:147-50.
48. Kelleher DJ. Patients learning from each other: self-help groups for people with diabetes. J R Soc Med 1991;84:595-7.
49. Constantino M, Hoskins PL, Fowler PM, Pech C, McFarlane R, Flack JR, et al. Interaction between diabetic patients, their general practitioners and a hospital diabetic clinic. Med J Aust 1991;155:515-8.
50. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992;268:63-7.
51. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 1996;276:1246-52.